Related Experiment Video
Updated: Apr 28, 2026
11:01
Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
11.0K
Biodegradable stents and non-biodegradable stents.
Minerva Cardioangiologica
|October 20, 2009
Summary
Biodegradable coronary stents offer a promising alternative to metallic drug-eluting stents (DES), potentially enabling natural artery healing. Newer DES designs also aim to improve safety and biocompatibility in interventional cardiology.
Area of Science:
- Interventional Cardiology
- Biomaterials Science
- Cardiovascular Engineering
Background:
- The coronary stent revolutionized interventional cardiology starting in 1986.
- Metallic drug-eluting stents (DES) have limitations, driving interest in biodegradable alternatives.
- Concerns regarding stent thrombosis have prompted development of improved DES.
Purpose of the Study:
- To review the current status of biodegradable coronary stents.
- To examine advancements in newer metallic drug-eluting stent (DES) technology.
- To discuss the ongoing development of the ideal coronary stent.
Main Methods:
- Review of clinical trial data for biodegradable stents.
- Analysis of preclinical development stages for novel stent technologies.
- Evaluation of newer metallic DES designs, including polymer-coated and polymer-free options.
Main Results:
- Biodegradable stents, made from polymers or metal alloys, aim to scaffold arteries for natural healing before degrading.
- Several biodegradable stents are in clinical trials, with many more in preclinical development.
- Newer metallic DES feature improved biocompatibility and polymer-free designs to address safety concerns.
Conclusions:
- Biodegradable stents represent a significant advancement, offering potential for natural arterial healing.
- Ongoing innovations in both biodegradable and metallic DES are crucial for developing the ideal coronary stent.
- The field of interventional cardiology is rapidly evolving with these new stent technologies.
